Swiss Life Asset Management Ltd Has $3.71 Million Stake in Docusign Inc. $DOCU

Swiss Life Asset Management Ltd lowered its holdings in Docusign Inc. (NASDAQ:DOCU) by 25.1% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 51,399 shares of the company’s stock after selling 17,260 shares during the period. Swiss Life Asset Management Ltd’s holdings in Docusign were worth $3,705,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Twin Peaks Wealth Advisors LLC bought a new position in shares of Docusign during the second quarter worth approximately $43,000. SJS Investment Consulting Inc. boosted its stake in shares of Docusign by 5,318.2% in the third quarter. SJS Investment Consulting Inc. now owns 596 shares of the company’s stock valued at $43,000 after buying an additional 585 shares during the period. CX Institutional grew its position in Docusign by 5,860.0% during the third quarter. CX Institutional now owns 596 shares of the company’s stock worth $43,000 after buying an additional 586 shares in the last quarter. Strategic Advocates LLC bought a new position in Docusign during the 3rd quarter worth $50,000. Finally, Bessemer Group Inc. increased its stake in Docusign by 66.9% during the 3rd quarter. Bessemer Group Inc. now owns 873 shares of the company’s stock worth $62,000 after acquiring an additional 350 shares during the period. Institutional investors and hedge funds own 77.64% of the company’s stock.

Key Stories Impacting Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Q4 beat — DocuSign reported Q4 revenue and EPS modestly above consensus and reiterated growth guidance, showing continued subscription momentum and giving a near‑term fundamental support for the stock. Proactive: DocuSign beats Q4 estimates
• Positive Sentiment: Large buyback authorized — The board approved a $2.0 billion increase (bringing total authorization to roughly $2.6B), representing a material portion of market cap; buybacks are a direct capital‑allocation tool that can support the share price and signal management confidence. DocuSign press release: buyback
• Neutral Sentiment: Higher trading volume — Volume spiked after the earnings release, which raises short‑term volatility and can amplify both rebounds and selloffs depending on flow. American Banking News: Volume Increase After Earnings
• Neutral Sentiment: Short‑interest reporting appears inconsistent — March short‑interest entries in the feed show anomalous “0”/NaN values, so there’s no clear short‑flow signal from these data points at this time.
• Negative Sentiment: Analyst cuts and cautious notes — Multiple major brokerages trimmed price targets and moved to more cautious ratings (examples include Morgan Stanley, RBC, UBS, JPMorgan, Piper Sandler, Wells Fargo and others), reducing near‑term upside expectations and contributing to selling pressure. American Banking News: Morgan Stanley Lowers Price Target
• Negative Sentiment: Insider sale disclosed — Senior executive Robert Chatwani sold ~16.7k shares (~$803k); while single insider sales can be routine, the filing has weighed on sentiment alongside the analyst downgrades. SEC Form 4: Insider Sale

Insider Buying and Selling at Docusign

In other news, CFO Blake Jeffrey Grayson sold 6,500 shares of the company’s stock in a transaction on Friday, January 9th. The shares were sold at an average price of $70.00, for a total value of $455,000.00. Following the sale, the chief financial officer directly owned 111,713 shares of the company’s stock, valued at approximately $7,819,910. This represents a 5.50% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider James P. Shaughnessy sold 12,000 shares of the stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $67.03, for a total transaction of $804,360.00. Following the sale, the insider owned 54,550 shares of the company’s stock, valued at approximately $3,656,486.50. This trade represents a 18.03% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 68,173 shares of company stock worth $4,324,684. Company insiders own 1.66% of the company’s stock.

Docusign Price Performance

DOCU stock opened at $47.23 on Monday. Docusign Inc. has a 1 year low of $40.16 and a 1 year high of $94.67. The stock has a market cap of $9.18 billion, a price-to-earnings ratio of 31.91, a P/E/G ratio of 1.94 and a beta of 1.03. The company has a 50 day simple moving average of $49.82 and a 200 day simple moving average of $63.88.

Docusign (NASDAQ:DOCU) last issued its earnings results on Tuesday, March 17th. The company reported $1.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.95 by $0.06. Docusign had a return on equity of 16.86% and a net margin of 9.60%.The business had revenue of $836.86 million during the quarter, compared to analysts’ expectations of $828.23 million. During the same quarter in the prior year, the firm earned $0.86 EPS. The business’s revenue for the quarter was up 7.8% compared to the same quarter last year. On average, equities research analysts anticipate that Docusign Inc. will post 1.17 EPS for the current fiscal year.

Docusign announced that its Board of Directors has authorized a share buyback program on Tuesday, March 17th that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the company to purchase up to 21% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s management believes its stock is undervalued.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on DOCU. Morgan Stanley cut their target price on Docusign from $90.00 to $69.00 and set an “equal weight” rating for the company in a research report on Wednesday, March 18th. Cantor Fitzgerald restated an “outperform” rating on shares of Docusign in a research report on Wednesday, December 17th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Docusign in a research report on Wednesday, January 21st. Wedbush reduced their price objective on shares of Docusign from $85.00 to $75.00 and set a “neutral” rating on the stock in a research note on Friday, December 5th. Finally, Jefferies Financial Group lowered shares of Docusign from a “buy” rating to a “hold” rating and decreased their target price for the company from $105.00 to $45.00 in a report on Monday, February 23rd. Five equities research analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $66.67.

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.